๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

High-dose-intensity combination chemotherapy for advanced sarcomas: a pilot study

โœ Scribed by Paolo Pronzato; Pierluigi Losardo; Floriana Pensa; Alessandra Tognoni

Publisher
Springer
Year
1998
Tongue
English
Weight
262 KB
Volume
41
Category
Article
ISSN
0344-5704

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Pilot study of high-dose, concurrent bio
Pilot study of high-dose, concurrent biochemotherapy for advanced melanoma
โœ Kevin B. Kim; Omar Eton; Mary Jo East; Cynthia Hodges; Nicholas E. Papadopoulos; ๐Ÿ“‚ Article ๐Ÿ“… 2004 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 91 KB

## Background: Durable complete response rates ranging from 5% to 20% have been reported in association with biochemotherapy for patients with metastatic melanoma, with response rates on the low end of this range being observed in trials that used lower doses and less intense treatment schedules. i

Combination chemotherapy for soft-tissue
Combination chemotherapy for soft-tissue sarcomas: A phase III study
โœ A. B. Cruz JR.; E. A. Thames JR.; J. B. Aust; G. Metter; G. Ramirez; W. S. Fletc ๐Ÿ“‚ Article ๐Ÿ“… 1979 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 544 KB

A total of 144 patients with advanced sarcomas were entered into a randomized prospective protocol with four treatment arms utilizing different combinations of chemotherapeutic agents. Of these, 120 patients (83%) were judged acceptable. Treatment #1: actinomycin-D (Act-D), 0.01 mg/kg IV, days 1-5;

Pilot study of sequential combination ch
Pilot study of sequential combination chemotherapy in advanced and recurrent retinoblastoma
โœ Advani, S. H. ;Rao, S. R. ;Lyer, R. S. ;Pai, S. K. ;Kurkure, P. A. ;Nair, C. N. ๐Ÿ“‚ Article ๐Ÿ“… 1994 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 321 KB

## Abstract Eight patients with advanced/recurrent retinoblastomas were treated with sequential combination chemotherapy incorporating cyclophosphamide, cisplatin, adriamycin, and etoposide. All patients achieved complete clinical response (CR) at the end of the first 75 day cycle. Three patients d

Advanced acquired immune deficiency synd
Advanced acquired immune deficiency syndrome-related Kaposi's sarcoma. Results of pilot studies using combination chemotherapy
โœ Parkash S. Gill; Mark U. Rarick; Byron Espina; Carmen Loureiro; Marjorie Bernste ๐Ÿ“‚ Article ๐Ÿ“… 1990 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 398 KB

Pilot studies were conducted to evaluate the toxicity and efficacy of two relatively marrow-sparing chemotherapy regimens in the treatment of advanced or progressive epidemic Kaposi's sarcoma. Chemotherapy regimens consisted of bleomycin (10 mg/m2), vincristine (1.4 mg/m2, 2 mg maximum) and Adriamyc